Literature DB >> 17906690

Overcoming chemoresistance of non-small cell lung carcinoma through restoration of an AIF-dependent apoptotic pathway.

M-A Gallego1, C Ballot, J Kluza, N Hajji, A Martoriati, L Castéra, C Cuevas, P Formstecher, B Joseph, G Kroemer, C Bailly, P Marchetti.   

Abstract

Non-small cell lung carcinomas (NSCLCs) are typically resistant against apoptosis induced by standard chemotherapy. We evaluated the effects of the two potential antitumor agents of the lamellarin class on a highly apoptosis-resistant NSCLC cell line. Both the marine alkaloid lamellarin-D and its synthetic amino derivative PM031379 induced the activation of Bax, the mitochondrial release of cytochrome c and apoptosis-inducing factor (AIF), as well as the activation of caspase-3. However, only PM031379 triggered cell death and sign of nuclear apoptosis coupled to the nuclear translocation of AIF. Depletion of AIF with small interfering RNA or microinjection of a neutralizing anti-AIF antibody largely prevented PM031379-induced cytotoxicity, underscoring the essential contribution of AIF to NSCLC killing. Using NSCLC cells lacking mitochondrial DNA, we showed that the generation of mitochondrial reactive oxygen species (ROS) was crucial for the PM031379-induced translocation of AIF to the nucleus and subsequently cell death. Pretreatment of NSCLC cells with menadione, a mitochondrial ROS generator, was able to restore the deficient chemotherapy-induced apoptosis of NSCLC cells. Altogether, these data suggest that mitochondrial ROS generation is crucial for overriding the chemoresistance of NSCLC cells. Moreover, this study delineates the unique mechanism of action of lamellarins as potential anticancer agents.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17906690     DOI: 10.1038/sj.onc.1210833

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  17 in total

1.  SRSF1 regulates the alternative splicing of caspase 9 via a novel intronic splicing enhancer affecting the chemotherapeutic sensitivity of non-small cell lung cancer cells.

Authors:  Jacqueline C Shultz; Rachel W Goehe; Charuta S Murudkar; Dayanjan S Wijesinghe; Eric K Mayton; Autumn Massiello; Amy J Hawkins; Prabhat Mukerjee; Ryan L Pinkerman; Margaret A Park; Charles E Chalfant
Journal:  Mol Cancer Res       Date:  2011-05-26       Impact factor: 5.852

Review 2.  Marine Mollusk-Derived Agents with Antiproliferative Activity as Promising Anticancer Agents to Overcome Chemotherapy Resistance.

Authors:  Maria Letizia Ciavatta; Florence Lefranc; Marianna Carbone; Ernesto Mollo; Margherita Gavagnin; Tania Betancourt; Ramesh Dasari; Alexander Kornienko; Robert Kiss
Journal:  Med Res Rev       Date:  2016-12-07       Impact factor: 12.944

3.  High temperature requirement A3 (HtrA3) promotes etoposide- and cisplatin-induced cytotoxicity in lung cancer cell lines.

Authors:  Daniah Beleford; Ramandeep Rattan; Jeremy Chien; Viji Shridhar
Journal:  J Biol Chem       Date:  2010-02-12       Impact factor: 5.157

4.  3D pharmacophore mapping using 4D QSAR analysis for the cytotoxicity of lamellarins against human hormone-dependent T47D breast cancer cells.

Authors:  Poonsiri Thipnate; Jianzhong Liu; Supa Hannongbua; A J Hopfinger
Journal:  J Chem Inf Model       Date:  2009-10       Impact factor: 4.956

5.  Synthetic and biological studies of tubulin targeting c2-substituted 7-deazahypoxanthines derived from marine alkaloid rigidins.

Authors:  Robert Scott; Menuka Karki; Mary R Reisenauer; Roberta Rodrigues; Ramesh Dasari; W Ross Smith; Stephen C Pelly; Willem A L van Otterlo; Charles B Shuster; Snezna Rogelj; Igor V Magedov; Liliya V Frolova; Alexander Kornienko
Journal:  ChemMedChem       Date:  2014-03-18       Impact factor: 3.466

6.  Effects of Coptis extract combined with chemotherapeutic agents on ROS production, multidrug resistance, and cell growth in A549 human lung cancer cells.

Authors:  Chengwei He; Rong Rong; Jing Liu; Jianbo Wan; Keyuan Zhou; Jing X Kang
Journal:  Chin Med       Date:  2012-04-30       Impact factor: 5.455

Review 7.  The mitochondrial death pathway: a promising therapeutic target in diseases.

Authors:  Sanjeev Gupta; George E N Kass; Eva Szegezdi; Bertrand Joseph
Journal:  J Cell Mol Med       Date:  2009-02-09       Impact factor: 5.310

8.  Anticancer alkaloid lamellarins inhibit protein kinases.

Authors:  Dianne Baunbaek; Nolwenn Trinkler; Yoan Ferandin; Olivier Lozach; Poonsakdi Ploypradith; Somsak Rucirawat; Fumito Ishibashi; Masatomo Iwao; Laurent Meijer
Journal:  Mar Drugs       Date:  2008-10-07       Impact factor: 5.118

9.  Rhaponticin suppresses osteosarcoma through the inhibition of PI3K-Akt-mTOR pathway.

Authors:  Suresh Mickymaray; Faiz Abdulaziz Alfaiz; Anand Paramasivam; Vishnu Priya Veeraraghavan; Nanthini Devi Periadurai; Krishna Mohan Surapaneni; Guangfeng Niu
Journal:  Saudi J Biol Sci       Date:  2021-05-08       Impact factor: 4.219

10.  The anoikis effector Bit1 displays tumor suppressive function in lung cancer cells.

Authors:  Xin Yao; Scott Jennings; Shubha Kale Ireland; Tri Pham; Brandi Temple; Mya Davis; Renwei Chen; Ian Davenport; Hector Biliran
Journal:  PLoS One       Date:  2014-07-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.